The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Amin, Jaymin Ghanshyam
    Financial Controller born in July 1970
    Individual (8 offsprings)
    Officer
    2012-06-06 ~ now
    OF - director → CIF 0
    Mr Jaymin Ghanshyam Amin
    Born in July 1970
    Individual (8 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Fotheringham, Ian
    Research Scientist born in May 1959
    Individual (4 offsprings)
    Officer
    2012-06-06 ~ now
    OF - director → CIF 0
    Mr Ian Fotheringham
    Born in May 1959
    Individual (4 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
Ceased 1
  • Srivastava, Sunil Kumar
    Director born in July 1957
    Individual (1 offspring)
    Officer
    2012-06-06 ~ 2014-01-31
    OF - director → CIF 0
parent relation
Company in focus

INGENZA BIOLOGICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
02023-05-01 ~ 2024-04-30
02022-05-01 ~ 2023-04-30
Fixed Assets - Investments
350,475 GBP2024-04-30
350,475 GBP2023-04-30
Fixed Assets
350,475 GBP2024-04-30
350,475 GBP2023-04-30
Debtors
Current
7 GBP2024-04-30
7 GBP2023-04-30
Current Assets
7 GBP2024-04-30
7 GBP2023-04-30
Creditors
Current, Amounts falling due within one year
-350,472 GBP2024-04-30
-350,472 GBP2023-04-30
Net Current Assets/Liabilities
-350,465 GBP2024-04-30
-350,465 GBP2023-04-30
Total Assets Less Current Liabilities
10 GBP2024-04-30
10 GBP2023-04-30
Net Assets/Liabilities
10 GBP2024-04-30
10 GBP2023-04-30
Equity
Called up share capital
10 GBP2024-04-30
10 GBP2023-04-30
Equity
10 GBP2024-04-30
10 GBP2023-04-30
Other Debtors
Current
7 GBP2024-04-30
7 GBP2023-04-30
Other Creditors
Current
350,472 GBP2024-04-30
350,472 GBP2023-04-30
Creditors
Current
350,472 GBP2024-04-30
350,472 GBP2023-04-30

  • INGENZA BIOLOGICS LIMITED
    Info
    Registered number SC425526
    Roslin Innovation Centre,charnock Bradley Building Easter Bush Campus, Bush Farm Road, Roslin EH25 9RG
    Private Limited Company incorporated on 2012-06-06 (13 years). The company status is Active.
    The last date of confirmation statement was made at 2024-06-06
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.